Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
7 Locations available
- Bevacizumab and Bortezomib in Patients With Advanced Malignancy
Conditions: Advanced Malignancy - Lymphoma - Myeloma - Solid Tumors
1 Location available
- Collection of Outcomes Data for Pregnant Patients With Cancer
Conditions: Solid Tumors - Pregnancy
1 Location available
- Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Childhood Malignant Fibrous Histiocytoma of Bone - Kidney Cancer - Lymphoma - Melanoma (Skin) - Neuroblastoma - Sarcoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor,
3 Locations available
- Assessing Response to Treatment in Patients With Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001
Conditions: Solid Tumors
3 Locations available
- Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Any Solid Tumor or Lymphoma
1 Location available
- Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
Conditions: Advanced Cancer
1 Location available
- Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Conditions: Advanced Solid Tumors
3 Locations available
- Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
Conditions: Cancer - Non-Small Cell Lung Cancer - Endometrial Carcinoma - Ovarian Carcinoma
3 Locations available
- Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer - Gastrointestinal Stromal Tumor - Intraocular Melanoma - Kidney Cancer - Lung Cancer - Melanoma (Skin) - Ovarian Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung
Conditions: Lung Cancer - Non Small Cell Lung Cancer - Solid Tumors
1 Location available
- A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
2 Locations available
- A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffe
Conditions: Solid Cancers
3 Locations available
- GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors
Conditions: Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Conditions: Kidney Cancer - Head and Neck Cancer - Breast Cancer - Non-small Cell Lung Cancer - Colorectal Cancer - Pancreatic Cancer - Ovarian Cancer - Esophageal Cancer - Gliomas
1 Location available
- ABT-888 and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Ovarian Epithelial Cancer or Primary Per
Conditions: Ovarian Cancer - Primary Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Study of NMS-1116354 in Solid Tumors
Conditions: Advanced Solid Tumors
1 Location available
- ABT-888 With or Without Mitomycin in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
Conditions: Solid Tumor - Breast Cancer - Ovarian Cancer - Pancreatic Cancer - Non-Small Cell Lung
2 Locations available
- A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors
Conditions: Cancer
2 Locations available
- Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: Leukemia - Unspecified Childhood Solid Tumor, Protocol Specific
21 Locations available
- Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
Conditions: Solid Tumors
1 Location available
- Dasatinib in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Liver Cancer - Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
10 Locations available
- Total Marrow Irradiation Added to an Alkylator-Intense Conditioning Regimen for Patients With High Risk or Relapsed Solid Tumors
Conditions: Brain and Central Nervous System Tumors - Kidney Cancer - Liver Cancer - Retinoblastoma - Sarcoma
1 Location available
- ABT-888 and Cyclophosphamide With Versus Without Doxorubicin in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
Conditions: Breast Cancer - Lymphoma - Lymphoproliferative Disorder - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Erlotinib and Temsirolimus for Solid Tumors
Conditions: Solid Tumors
1 Location available
- A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
Conditions: Cancer - Oncology - Tumors - Advanced Malignancy - Advanced Solid Tumors - Oncology Patients
3 Locations available
- Methionine PET/CT Studies In Patients With Cancer
Conditions: Brain Tumors and /or Solid Tumors Including: - Brain Stem Glioma - High Grade CNS Tumors - Ependymoma - Medulloblastoma - Craniopharyngioma - Low Grade CNS Tumors - Hodgkin Lymphoma - Non Hodgkin Lymphoma - Ewing Sarcoma - Osteosarcoma - Rhabdomyosarcoma
1 Location available
- A Study of of MORAb-004 in Subjects With Solid Tumors
Conditions: Solid Tumor
2 Locations available
- Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors
Conditions: Brain Metastases
1 Location available
- Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- ABT-888 in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer - Fallopian Tube Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer - Pancreatic Cancer - Peritoneal Cavity Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Pr
1 Location available
- Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent
Conditions: Solid Tumors - Lymphoma
2 Locations available
- Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors
Conditions: Advanced or Metastatic Solid Tumors
1 Location available
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Conditions: Refractory Head and Neck Cancer, Squamous Cell Carcinoma of the Skin, Carcinoma of the Breast, and Malignant Melanoma
4 Locations available
- A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer
Conditions: Advanced Solid Tumors
1 Location available
- Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant
Conditions: Solid Tumors - Glioblastoma Multiforme - Recurrent Malignant Gliomas
2 Locations available
- Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers
Conditions: Breast Cancer - Neoplasm Metastasis
1 Location available
- Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Kidney Cancer - Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- AFP464 in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Kidney Cancer - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Conditions: Ovarian Cancer - Renal Cancer - Non-small Cell Lung Cancer - Small Cell Lung Cancer - Solid Tumors - Multiple Myeloma
7 Locations available
- Gossypol, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
Conditions: Lung Cancer - Unspecified Adult Solid Tumor, Protocol Specific
5 Locations available
- Studying Patients With a Personal or Family History of Cancer Caused by a Virus
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Sarcoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Conditions: Solid Tumors
4 Locations available
- A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer
Conditions: Advanced or Metastatic Solid Tumors - Advanced or Metastatic Breast Cancer
1 Location available
- A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors
Conditions: Solid Tumor
1 Location available
- Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Conditions: Solid Tumors - Neoplasms, Breast - Cancer
11 Locations available
- Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tum
Conditions: Solid Tumors - Ovarian Cancer
7 Locations available
- Dose-escalation Study of Oral CX-4945
Conditions: Advanced Solid Tumors - Breast Cancer - Inflammatory Breast Cancer - Castleman's Disease - Multiple Myeloma
4 Locations available
- A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Conditions: Advanced or Metastatic Solid Tumors - Cancer - Solid Cancers
4 Locations available
- HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
Conditions: Non-CNS Solid Tumors
1 Location available
- Short-Term Fasting: Impact on Toxicity
Conditions: Fasting in Malignant Solid Tumors
1 Location available
- Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Neuroblastoma - Unspecified Childhood Solid Tumor, Protocol Specific
25 Locations available
- Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors
Conditions: Solid Tumors
3 Locations available
- Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma
Conditions: Cancer
3 Locations available
- A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Conditions: ErbB2 Overexpressing - Solid Tumors - Metastatic Breast Cancer - Neoplasms, Breast
8 Locations available
- Molecular Analysis Of Solid Tumors
Conditions: Pediatric Solid Tumors
1 Location available
- A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas
Conditions: Neoplasms - Lymphoma
1 Location available
- Imaging and Biomarkers of Hypoxia in Solid Tumors
Conditions: Neoplasms
1 Location available
- A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor
Conditions: Advanced Solid Tumors
2 Locations available
- Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
Conditions: Neoplasms - Hematologic Neoplasms
1 Location available
- Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
Conditions: Cancer
2 Locations available
- Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors
Conditions: Leukemia - Solid Tumors
1 Location available
- A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
Conditions: Breast Cancer, - Advanced Solid Tumors, - Cowden Syndrome
8 Locations available
- Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
Conditions: Solid Tumors
1 Location available
- A Study of QBI-139 in Subjects With Advanced Solid Tumors
Conditions: Solid Tumors
2 Locations available
- A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
1 Location available
- Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors
Conditions: Neoplasms
1 Location available
- First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor EMD 1214063 in Subjects With Advanced Solid Tumors
Conditions: Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available
1 Location available
- A Combination Therapy Study of MK2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010 AM5)
Conditions: Locally Advanced or Metastatic Solid Tumors
2 Locations available
- Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors
Conditions: Pediatric Solid Tumors
1 Location available
- Trial of Bi-shRNA-furin and Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented Autologous Tumor Cell Vaccine for Advanced Cancer
Conditions: Solid Tumors
1 Location available
- A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Conditions: Advanced Solid Tumors
6 Locations available
- A Phase 1 Study of MLN8237 in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regime
Conditions: Advanced Solid Tumors - Adenocarcinoma of the Prostate
1 Location available
- Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Recurrent or Refractory Medulloblastoma - Locally Advanced or Metastatic Basal Cell Carcinoma
2 Locations available
- Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors
Conditions: Neoplasm Metastases
1 Location available
- Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia
Conditions: Leukemia - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Safety, Pharmacokinetics and Clinical Activity of Oral ON 01910.Na in Solid Tumors
Conditions: Solid Tumor
1 Location available
- An Extension Protocol for Subjects Who Were Previously Enrolled in Other ARQ 197 Protocols
Conditions: Advanced Solid Tumors
5 Locations available
- Study of PX-866 and Docetaxel in Solid Tumors
Conditions: Non Small Cell Lung Cancer (NSCLC) - Squamous Cell Carcinoma of the Head and Neck (SCCHN)
28 Locations available
- MEK Inhibitor AZD6244 and Cetuximab Treating Patients With Advanced or Refractory Solid Tumors That Cannot Be Removed By Surgery
Conditions: Colorectal Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients W
Conditions: Metastatic Melanoma
2 Locations available
- PXD101 and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
5 Locations available
- Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
Conditions: Solid Tumor - Urethral Cancer
1 Location available
- Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Biliary Cancer - Pancreatic Cancer
1 Location available
- Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Solid Tumors That Did Not Respond to Treatment
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib
Conditions: Solid Tumors
1 Location available
- IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
Conditions: Breast Cancer - Lung Cancer - Melanoma - Pancreatic Cancer - Solid Tumors
1 Location available
- A Trial of RAD001 and Avastin in Children With Recurrent Solid Tumors
Conditions: Recurrent or Refractory Solid Tumors - CNS Malignancies
1 Location available
- FAU in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer - Breast Neoplasms - Breast Tumors - Cancer - Locally Recurrent and Metastatic Breast Cancer - Metastases - Metastatic Cancer - Oncology - Solid Tumors - Tumors
5 Locations available
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
97 Locations available
- Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors
Conditions: Solid Tumors
1 Location available
- A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors
Conditions: Non-Small Cell Lung Cancer, Solid Cancers
2 Locations available
- Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function
Conditions: Advanced Solid Tumors
1 Location available
- Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors
Conditions: Triple Negative Breast Cancer
1 Location available
- Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Conditions: Advanced Solid Tumors
1 Location available
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Solid Cancers
3 Locations available
- First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors
Conditions: Solid Tumors
1 Location available
- Safety Study of Live Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
Conditions: Solid Tumor Malignancies
2 Locations available
- A Study of IMC-RON8 in Advanced Solid Tumors
Conditions: Cancer
2 Locations available
- Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors
Conditions: Neoplasm - Cancer - Tumors
4 Locations available
- Biomarkers of RO4929097and Other Drugs in Treating Patients With Metastatic or Unresectable Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma of the Pancreas - Advanced Solid Tumors - Cancer - Cancer of Pancreas - Cancer of the Pancreas - Metastases - Metastatic Cancer - Metastatic Pancreatic Cancer - Pancreas Cancer - Pancreatic Cancer - Bone Metastases - Endocrine Cancer - Onco
23 Locations available
- Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
Conditions: Ewing's Sarcoma - Soft Tissue Sarcoma - Hepatoblastoma - Hodgkin's Disease - Germ Cell Tumor
1 Location available
- Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors
Conditions: Osteosarcoma
1 Location available
- Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
Conditions: Refractory Solid Tumors - Leukemia
1 Location available
- Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Trial In Patients With Advanced Cancer And Leukemia
Conditions: Neoplasms by Histologic Type - Leukemia, Lymphoid - Leukemia, T-Cell - Solid Tumors
6 Locations available
- Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors
Conditions: Metastatic Solid Tumors
3 Locations available
- A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Re
Conditions: Refractory Solid Tumors in Children
1 Location available
- A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors
1 Location available
- Safety Study of PLX108-01 in Patients With Solid Tumors
Conditions: Solid Tumors - Mucoepidermal Carcinoma (MEC) of the Salivary Gland - Pigmented Villo-nodular Synovitis (PVNS) - Gastrointestinal Stromal Tumors (GIST) - Anaplastic Thyroid Carcinoma (ATC) - Solid Tumors With Documented Malignant Pleural or Peritoneal Effu
10 Locations available
- Hydroxychloroquine + Vorinostat in Advanced Solid Tumors
Conditions: Advanced Solid Tumor
1 Location available
- Dose-Escalation Phase 1 Study of G-202 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors
3 Locations available
- Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Conditions: Cancer - Solid Tumors - Lymphoma - Malignancy
3 Locations available
- Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
Conditions: Sarcoma - Endocrine Tumors - Neuroblastoma - Retinoblastoma - Renal Cancer
2 Locations available
- Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Conditions: Neoplasm Malignant
13 Locations available
- A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
Conditions: Advanced and Selected Solid Tumors
2 Locations available
- A Database Study for Hematopoietic Stem Cell Transplantation and Marrow Injuries
Conditions: Autologous Stem Cell Transplantation - Allogeneic Stem Cell Transplantation - Solid Tumors - Blood Cancers
1 Location available
- Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
Conditions: Neuroblastoma - Rhabdomyosarcoma - Lymphoma - Wilm's Tumor - Ewing's Sarcoma
2 Locations available
- A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
Conditions: Metastatic or Unresectable Solid Tumor Malignancy
3 Locations available
- Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1
Conditions: NY-ESO-1 Positive Solid Tumors or Melanoma
2 Locations available
- Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
Conditions: Advanced Solid Tumors - Metastatic Colorectal Cancer
1 Location available
- A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Conditions: Solid Tumors
3 Locations available
- AT13387 in Treating Patients With Refractory Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- AT13387 in Adults With Refractory Solid Tumors
Conditions: Solid Tumors - Breast Cancer
1 Location available
- Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors
Conditions: Neurotoxicity - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- E7389 and Cisplatin in Treating Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
7 Locations available
- Safety Study of Infusion of SGT-53 to Treat Solid Tumors
Conditions: Neoplasm
1 Location available
- Sunitinib in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
Conditions: Kidney Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors
3 Locations available
- Phase I Study of Vorinostat and Sorafenib in Advanced Cancer
Conditions: Advanced Solid Tumors
1 Location available
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphocytic, Acute, T-Cell - Juvenile Myelomonocytic Leukemia Lymphoblastic - T-cell Lymphoblastic Lymphoma - Myelodysplastic Syndrome
1 Location available
- Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Conditions: MDS - AML - Solid Tumors - Multiple Myeloma - Non-Hodgkin's Lymphoma - Hodgkin's Disease
8 Locations available
- A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ova
Conditions: Cancer - Carcinoma - Fallopian Tube Cancer - Gynecological Malignancies - Metastases - Oncology - Ovarian Cancer - Solid Tumors - Tumors
8 Locations available
- Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
Conditions: Cancer
1 Location available
- Submission of Stem Cell Transplant Data to CIBMTR and NMDP
Conditions: Autologous Stem Cell Transplantation - Allogeneic Stem Cell Transplantation - Solid Tumors - Blood Cancers
1 Location available
- A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Conditions: Advanced Solid Tumors With FGFR1 Amplication, - Advanced Solid Tumors With FGFR2 Amplication, - Advanced Solid Tumors With FGFR3 Mutation
7 Locations available
- Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function
Conditions: Advanced Solid Tumors
1 Location available
- PD 0332991 in Treating Patients With Refractory Solid Tumors
Conditions: Adult Solid Tumor - Adenocarcinoma of the Colon - Adenocarcinoma of the Rectum - Adult Central Nervous System Germ Cell Tumor - Adult Teratoma - Benign Teratoma - Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - Famili
1 Location available
- Safety Study of AB0024 in Patients With Advanced Solid Tumors
Conditions: Solid Tumors - Cancer
2 Locations available
- An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas
Conditions: Neoplasms - Lymphoma
1 Location available
- A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Conditions: Solid Tumor - Anaplastic Thyroid Cancer
1 Location available
- LMP400 and LMP776 in Treating Patients With Relapsed Solid Tumors or Lymphomas
Conditions: Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Conditions: Advanced Solid Malignant Tumors - Advanced Ovarian Cancer
4 Locations available
- Safety Study of X-82 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors
2 Locations available
- A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
Conditions: Solid Tumors
2 Locations available
- Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
Conditions: Solid Tumor - Colorectal Cancer - Endometrial Cancer
3 Locations available
- Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Conditions: Solid Tumors - Lymphomas
1 Location available
- Abraxane and Alimta in Advanced Solid Tumors
Conditions: Breast Cancer - Lung Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Panitumumab Pediatric Study
Conditions: Solid Tumors
6 Locations available
- Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors
Conditions: Brain Metastases - Solid Tumors
4 Locations available
- A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Conditions: Advanced Malignancy - Advanced Solid Tumors - Cancer - Solid Tumors - Tumors
2 Locations available
- Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
Conditions: Colorectal Cancer - Head and Neck Cancer - Neoplasm Metastasis
3 Locations available
- Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
Conditions: Advanced Non-Hematologic Malignancies
4 Locations available
- Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma
Conditions: Advanced Solid Tumors - Lymphomas
2 Locations available
- A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors
4 Locations available
- Intraperitoneal Radioimmunotherapy With 131I-8H9 for Patients With Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneu
Conditions: Peritoneal Cancer
1 Location available
- A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung
Conditions: NSCLC - Solid Tumors
1 Location available
- ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Ovarian Cancer - Prostate Cancer
1 Location available
- Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Conditions: Metastatic Liver Disease
1 Location available
- A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Advanced Solid Tumor - Lymphomas
3 Locations available
- A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Sm
Conditions: Small Cell Lung Cancer and Other Solid Tumors
2 Locations available
- A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Conditions: Advanced Solid Tumors
5 Locations available
- Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- High-Dose or Low-Dose Vorinostat in Combination With Carboplatin in Treating Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Conditions: Solid Tumors - Relapsed/Refractory Sarcomas
2 Locations available
- Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors
Conditions: Solid Tumors
4 Locations available
- A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors
Conditions: Solid Tumor
1 Location available
- Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
Conditions: Solid Tumors - Non-Small Cell Lung Cancer (NSCLC)
1 Location available
- A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases
Conditions: Neoplasms - Liver Metastases
1 Location available
- Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Young Patients With Relapsed or Refractory Solid Tumors
Conditions: Unspecified Childhood Solid Tumor, Protocol Specific
21 Locations available
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
86 Locations available
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Conditions: Brain and Central Nervous System Tumors - Breast Cancer - Colorectal Cancer - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors
Conditions: Solid Tumor
5 Locations available
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
8 Locations available
- A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors
Conditions: Solid Tumor Malignancies
1 Location available
- A Phase 1 Study of 1-MT in Combination With Docetaxel in Metastatic Solid Tumors
Conditions: Solid Tumor
5 Locations available
- A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
Conditions: Advanced Solid Tumors - With an Alteration of the PIK3CA Gene
4 Locations available
- A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma
Conditions: Solid Cancers
2 Locations available
- Safety Study of Sterile Compound c31510 for Injection to Subjects With Solid Tumors
Conditions: Solid Tumour
1 Location available
- MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Conditions: Solid Organ Tumors
15 Locations available
- Endoxifen in Adults With Hormone Receptor-Positive Solid Tumors
Conditions: Hormone Receptor-Positive Breast - Gynecologic - Desmoid - Hormone Receptor-Positive Neoplasms
1 Location available
- AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer
Conditions: Colonic Neoplasms - Cancer of the Colon - Colon Cancer - Colon Neoplasms - Colonic Cancer
1 Location available
- Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Conditions: Urethral Neoplasms - Neoplasms, Urethral - Ureter Cancer - Cancer of the Urethra - Urethral Cancer
1 Location available
- Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma - Solid Tumour
1 Location available
- Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Solid Tumors
3 Locations available
- A Study of the Safety, Tolerability, and Efficacy of SCH 900353 in Participants With Advanced Solid Tumors (P06203 AM2)
Conditions: Tumor, Solid
3 Locations available
- A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer
Conditions: Advanced Solid Tumors
1 Location available
- ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors
Conditions: Advanced Solid Tumors
2 Locations available
- First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors
Conditions: Neoplasm Malignant
2 Locations available
- A Study of RO5045337 in Patients With Solid Tumors
Conditions: Neoplasms
2 Locations available
- Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer
Conditions: Solid Tumor - Kidney Cancer
2 Locations available
- Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors
Conditions: Solid Tumors
3 Locations available
- A Study of PNT2258 in Patients With Advanced Solid Tumors
Conditions: Cancer - Lymphoma - Prostate - Melanoma
1 Location available
- Hormone Blockade in Combination With Targeted Agents
Conditions: Solid Tumors - Advanced Cancer
1 Location available
- Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
Conditions: Hypertension - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
Conditions: Advanced Solid Tumors - Tumors - Cancer
1 Location available
- Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors
Conditions: Unspecified Childhood Solid Tumor, Protocol Specific
20 Locations available
- A Study of AMG 337 in Subjects With Advanced Solid Tumors
Conditions: Advanced Malignancy - Advanced Solid Tumors - Cancer - Oncology - Oncology Patients - Tumors
4 Locations available
- A Study of ABT-806 in Subjects With Advanced Solid Tumor Types
Conditions: Advanced Solid Tumors
3 Locations available
- Study of REGN910 (SAR307746)
Conditions: Solid Tumors
1 Location available
- Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Childhood Solid Tumor, Protocol Specific
21 Locations available
- A Study of DS-2248, in Subjects With Advanced Solid Tumors
Conditions: Solid Tumors - Non-small Cell Lung Carcinoma
2 Locations available
- A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors
Conditions: Neoplasms
2 Locations available
- Study to Evaluate the Safety and Tolerability of Weekly IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Conditions: Cancer
2 Locations available
- Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors
Conditions: Advanced Solid Tumors
1 Location available
- Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
Conditions: Adult Solid Tumor
4 Locations available
- Acupressure in Controlling Nausea in Young Patients With Central Nervous System or Solid Tumors Receiving Cisplatin-Containing Chemotherapy
Conditions: Brain and Central Nervous System Tumors - Nausea and Vomiting - Unspecified Childhood Solid Tumor, Protocol Specific
19 Locations available
- Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Locally Advanced Solid Tumor - Metastatic Solid Tumor - Breast Cancer - Non Small Cell Lung Cancer - Melanoma - Colorectal Cancer
2 Locations available
- Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
Conditions: Solid Tumors
2 Locations available
- Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor
1 Location available
- A Study of LY2812176 in Multiple Myeloma or Advanced Solid Tumors
Conditions: Multiple Myeloma - Solid Tumors
1 Location available
- Lapatinib and Cetuximab in Patients With Solid Tumors
Conditions: Colorectal Cancer - Lung Cancer - Head and Neck Cancer
1 Location available
- Dose Escalation, Combination Chemotherapy Safety Study of TL32711, in Subjects With Advanced or Metastatic Solid Tumors
Conditions: Cancer
6 Locations available
- Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors
1 Location available
- Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors
Conditions: Solid Tumors - Brain Tumors - Brain Metastases
1 Location available
- Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors
Conditions: Solid Tumors
3 Locations available
- Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Conditions: Advanced or Recurrent Solid Tumors
2 Locations available
- A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Conditions: Metastatic Cancer - Cancer - Solid Tumors
3 Locations available
- Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
Conditions: Solid Tumors
2 Locations available
- A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
Conditions: Solid Tumor - Hematological Malignancy
1 Location available
- Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Advanced Lymphoma, Multiple Myeloma, or Solid Tumors
Conditions: Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Precancerous Condition - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
Conditions: Advanced Solid Tumors - Kidney Disease - Renal Impairment
4 Locations available
- A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
Conditions: Neoplasms
2 Locations available
- Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometri
Conditions: Solid Tumors and Advanced Endometrial Cancer - Endometrial Cancer - Second-line Treatment - VEGF
2 Locations available
- Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients Wit
Conditions: Solid Tumors - Advanced Thyroid Cancer
2 Locations available
- Sorafenib (BAY 43-9006) to Treat Children With Solid Tumors or Leukemias
Conditions: Refractory Solid Tumors - Refractory Leukemias
1 Location available
- Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Conditions: Solid Tumors
4 Locations available
- A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
Conditions: Advanced and Selected Solid Tumors
2 Locations available
- Oral Azacitidine as a Single Agent and in Combination With Carboplatin or Abraxane® in Subjects With Relapsed or Refractory Solid Tumors
Conditions: Relapsed or Refractory Solid Tumors
4 Locations available
- Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors
Conditions: Neoplasms - Cancer
2 Locations available
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Conditions: Adult Anaplastic Astrocytoma - Adult Anaplastic Oligodendroglioma - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Mixed Glioma - Adult Primary Hepatocellular Carcinoma - Chondrosarcoma - Clear Cell Sarcoma of the Kidney -
1 Location available
- Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Registry Study for Proton Therapy Outcomes
Conditions: Solid Tumors
2 Locations available
- Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
Conditions: Head and Neck Cancer - Advanced Solid Tumors
1 Location available
- Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
Conditions: Ewing's Sarcoma - Osteosarcoma - Astrocytoma - Atypical Teratoid/Rhabdoid Tumor - Ependymoma - Germ Cell Tumor - Glioma - Medulloblastoma - Rhabdoid Tumor - Retinoblastoma - Clear Cell Sarcoma - Renal Cell Carcinoma - Wilms Tumor - Hepatoblastoma - Neurob
1 Location available
|